| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.6M | -29.6% |
| SG&A Expense | $8.5M | +31.9% |
| Operating Income | -$10.1M | -15.9% |
| Pre-tax Income | -$9.9M | -112.8% |
| Income Tax | -$30K | — |
| Net Income | -$9.8M | -112.1% |
| EPS (Basic) | -$0.76 | -33.3% |
| EPS (Diluted) | -$0.76 | -33.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | -27.8% |
| Inventory | $1.7M | +819.9% |
| Current Assets | $4.8M | +9.4% |
| Total Assets | $11.8M | -0.4% |
| Current Liabilities | $3.7M | +84.0% |
| Total Liabilities | $3.9M | +75.3% |
| Stockholders' Equity | $7.9M | -17.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.5M | -32.2% |
| Capital Expenditures | $698K | +28.7% |
| Investing Cash Flow | -$698K | +77.6% |
| Financing Cash Flow | $8.0M | -34.4% |
| Free Cash Flow | -$9.2M | -32.0% |